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Background
Serotonin Syndrome Associated With Therapeutic Metaxalone Dosing
in a Patient With Cirrhosis
Discussion:
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Metaxalone has recently been associated with serotonin 
syndrome (SS) in the setting of overdose. We report the first 
case of SS with therapeutic metaxalone dosing in a cirrhosis 
patient.
Case Report
A 65-year-old male presented to the ED with altered mental 
status. He was recently prescribed metaxalone (800mg every 
12 hours) for a back injury. Family reported within one hour of 
each ingestion the patient developed confusion, diaphoresis, 
facial flushing, and muscle stiffness. Symptoms would 
gradually improve over several hours but then worsen with 
each subsequent dose. Medical history included cirrhosis, 
depression, and thrombocytopenia. Home medications 
included venlafaxine, quetiapine, propranolol, and rifaximin.
Initial vital signs were BP of 154/62, HR of 78, RR of 20, 
temperature of 38.2 C, and oxygen saturation of 94%. The 
patient was confused, agitated, and profusely diaphoretic. 
Patient had ocular clonus, mydriasis, hyper-rigidity and 
sustained clonus of the lower extremities. Lab values showed 
platelets 114 thou/cmm, creatinine 1.68 mg/dl, lactate 3.2  
mmol/L, ammonia 90 umol/L, normal aminotransferases, and a 
negative urine drug screen. EKG showed normal sinus rhythm. 
Computed tomography of the head showed no abnormality. 
Metaxalone level, drawn approximately 12 hours after last 
dose, was 11mcg/ml (peak plasma concentrations average 
1.7mcg/mL three hours after 800mg dose).
The patient was intubated for airway protection using 
etomidate and rocuronium. Diagnosis of SS was suspected. 
Fentanyl was started for sedation, however, this was replaced 
Metaxalone, a 2-oxazolidinone, has been theorized to have reversible 
MAOI properties at elevated concentrations. Previously reported cases 
involve overdoses of metaxalone as a single drug or in combination 
with another pro-serotonergic agent. This is the first case of SS in 
therapeutic metaxalone dosing with a confirmed serum concentration.
Metaxalone primarily undergoes hepatic metabolism although the 
impact of hepatic disease on the pharmokinetics of metaxalone has 
not been established. We propose that cirrhosis led to decreased 
elimination of metaxalone and an elevated serum concentration. 
Supratherapeutic metaxalone serum concentrations combined with a 
SNRI triggered SS.
Conclusion
Hepatic insufficiency may lead to accumulation of serum metaxalone. 
At high concentrations or when combined with another pro-
serotonergic agent this can lead to SS.
with midazolam. Hyperthermia resolved after intubation without 
antipyretics. Serotongeric symptoms gradually improved over several 
days. The patient had a prolonged hospital course complicated by GI 
bleeding and hepatorenal syndrome.
